Tobias Keck

from Wikipedia, the free encyclopedia

Tobias Keck (born April 26, 1971 in Nuremberg ) is a German surgeon and director of the surgical clinic at the Schleswig-Holstein University Medical Center in Lübeck .

Career

Keck studied medicine in Erlangen, Stanford and UCSD San ​​Diego from 1990 to 1997. In 1997 he completed his doctorate in Erlangen as well as the American state examination USMLE Step I and II, whereupon he took up a position as an assistant doctor at the surgical university clinic in Heidelberg. From 1999 to 2002 Keck was Surgical Research Fellow at Harvard Medical School in Boston, USA, in the laboratory of Andrew Warshaw and from 2002 to 2004 he was an assistant doctor at the University of Freiburg Surgical Clinic. Keck graduated as a specialist in surgery in 2004, whereupon he became senior physician at the University of Freiburg Surgical Clinic in 2005 and received his habilitation and Venia Legendi at the University of Freiburg. In 2006 Keck received the additional designation for special surgical intensive medicine and was appointed investigator for clinical studies. Since 2007 he has been specializing in visceral surgery and heading the International Pancreatic Carcinoma Center in Freiburg. In 2008 he completed the MBA in Health Care Management from the TU Dresden, whereupon he was appointed senior physician in charge in 2009 and was awarded the extraordinary professorship in surgery. He has been a Fellow of the American College of Surgeons (FACS) since 2009 and a Fellow of the European Board of Surgery (FEBS) since 2010.

On December 1, 2012, Keck was appointed Clinic Director of the Clinic for General Surgery on the Lübeck campus of the Schleswig-Holstein University Medical Center. Since March 1, 2013 he has been head of the UCCL (University Cancer Center Lübeck).

Clinical focus

Tobias Keck's clinical focus covers the entire spectrum of visceral surgery. The focus is on all minimally invasive surgery. There is special competence in minimally invasive pancreatic surgery. Keck's research focus is the epithelio-mesenchymal transition (EMT) in migration and metastasis in pancreatic cancer. Keck is chairman of the Surgical Working Group Liver Galle Pancreas of the German Society for General and Visceral Surgery (DGAV) and on the advisory board of the DFG.

Publications

  • U. Wellner, J. Schubert, UC Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, VG Brunton, J. Morton, O. Sansom , J. Schüler, MP Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. In: Nat Cell Biol. Vol. 11, No. 12, Dec 2009, pp. 1487-1495.
  • T. Keck, J. Balcom, B. Antoniu, C. Fernandez-del-Castillo, AL Warshaw: Matrix metalloproteinase-9 enhances neutrophil migration and alveolar capillary leakage in pancreatitis associated lung injury. In: Gastroenterology. Vol. 122, 2002, pp. 188-201.
  • MK Diener, CM Seiler, I. Rossion, J. Kleeff, M. Glanemann, G. Butturini, A. Tomazic, CJ Bruns, OR Busch, S. Farkas, O. Belyaev, JP Neoptolemos, C. Halloran, T. Keck , M. Niedergethmann, K. Gellert, H. Witzigmann, O. Kollmar, P. Langer, U. Steger, J. Neudecker, F. Berrevoet, S. Ganzera, MM Heiss, SP Luntz, T. Bruckner, M. Kieser , MW Büchler: Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomized, controlled multicenter trial. In: Lancet. Volume 377, No. 9776, Apr 30, 2011, pp. 1514-1522.
  • T. Keck, G. Marjanovic, C. Fernandez-del-Castillo, F. Makowiec, O. Schäfer, R. Rodriguez, O. Razo, UT Hopt, AL Warshaw: The Inflammatory Pancreatic Head Mass: Significant Differences in the Anatomic Pathology of German and American Patients with Chronic Pancreatitis Determine Very Different Surgical Strategies. In: Ann Surg. Volume 249, No. 1, Jan 2009, pp. 105-110.
  • D. Bausch, T. Pausch, T. Krauss, UT Hopt, C. Fernandez-del-Castillo, AL Warshaw, SP Thayer, T. Keck: Neutrophil granulocyte derived Matrix Metalloproteinase-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. In: Angiogenesis. Volume 14, No. 3, Sep 2011, pp. 235-243.

Memberships

  • 1999: International Association of Pancreatology
  • 2000: American Pancreatic Association
  • 2000: German Society for Surgery (DGC)
  • 2001: American Gastroenterological Association (AGA)
  • 2001: Society for Surgery of the Alimentary Tract (SSAT)
  • 2001: Pancreas Club
  • 2001: German Transplant Society
  • 2002: German Pancreas Club
  • 2004: Surgical Working Group Liver-Gall-Pancreas (CALGP)
  • 2005: Surgical Working Group Intensive Care Medicine (CAI)
  • 2006: Surgical Research Section
  • 2007: German Society for General and Visceral Surgery (DGAV)
  • 2009: International Association of the Hepato-Pancreatico-Biliary-Association
  • 2009: American College of Surgeons
  • 2009: Fellow American College of Surgeons
  • 2010: Surgical Working Group on Minimally Invasive Surgery
  • 2010: Fellow European Board of Surgical Oncology

Individual evidence

  1. ↑ Tobias Keck on the website of the University Hospital Schleswig-Holstein. Retrieved May 21, 2017 .
  2. ↑ Tobias Keck on the website of the University of Lübeck. Retrieved May 22, 2017 .
personal data
SURNAME Cheeky, Tobias
BRIEF DESCRIPTION German surgeon and director of the surgical clinic at the Schleswig-Holstein University Medical Center in Lübeck
DATE OF BIRTH April 26, 1971
PLACE OF BIRTH Nuremberg